| URL | https://finance.yahoo.com/sectors/healthcare/artic |
| Source | yahoo finance |
| Date Published | 03/19/2026 |
| Company/Division name | LGM Pharma |
| Parent company | New Harbor Capital |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2026 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 4 |
| City reshored to: | Rosenberg |
| State(s) reshored to: | TX |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | pharmaceuticals |
| What non-domestic negative factors made offshoring less attractive? | Supply chain interruption |